Skip to main content

Abstract

Vitiligo is an acquired chronic disease characterized by circumscribed depigmented macules and patches that result from a progressive loss of functional melanocytes. Its course is unpredictable. Topical corticosteroids and topical calcineurin inhibitors can be used alone or in combination in localized disease. Phototherapy is the treatment of choice in generalized disease. Narrowband UVB phototherapy has superseded psoralen plus UVA (PUVA) photochemotherapy in the treatment of vitiligo because it has been shown to be clinically more effective and it is characterized by a better side effect profile. Surgical treatment with autologous transplantation techniques may be an option for patients with limited and stable disease. Depigmentation should be considered when vitiligo patients have >80 % cutaneous involvement and are recalcitrant to repigmentation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Further Reading

  • Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65:473–91.

    Article  Google Scholar 

  • Felsten LM, Alikhan A, Petronic-Rosic V. Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol. 2011;65:493–514.

    Article  Google Scholar 

  • Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol. 2008;159:1051–76.

    Article  CAS  Google Scholar 

  • Lotti TM, Hercogová J, Schwartz RA, Tsampau D, Korobko I, Pietrzak A, et al. Treatments of vitiligo: what’s new at the horizon. Dermatol Ther. 2012;25 Suppl 1:S32–40.

    Article  Google Scholar 

  • Nicolaidou E, Antoniou C, Stratigos A, Katsambas A. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol. 2009;6:470–7.

    Article  Google Scholar 

  • Ortonne JP, Passeron T. Vitiligo. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. China: Elsevier-Saunders; 2012. p. 1023–30.

    Google Scholar 

  • Taieb A, Alomar A, Böhm M, Dell’anna ML, De Pase A, Eleftheriadou V, et al. Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2013;168(1):5–19.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Electra Nicolaidou .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Nicolaidou, E., Katsambas, A.D., Lotti, T.M. (2015). Vitiligo. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_104

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45139-7_104

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45138-0

  • Online ISBN: 978-3-662-45139-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics